Price $58.79 |
Market Cap
9.49B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
16.7
|
P/B
3.16
|
P/S
1.02
|
Dividend %
-
|
|
P/CF
45.5
|
P/FCF
22.0
|
Op. Cash Flow
524.3K
|
FCF
3.0
|
|
Op. Margin
5.90%
|
Net Margin
6.30%
|
ROE
20.00%
|
ROI
14.90%
|
|
ROA
8.10%
|
EPS Growth
27.80%
|
Current Ratio
1.6
|
Debt/Equity
20.80%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Teva Pharmaceutical Industries (TEVA) | $8.72 | - | - | 10.43B | Strong Buy |
| Esperion Therapeutics Inc (ESPR) | $37.52 | - | - | 946.1M | Strong Buy |
| Dynasil Corporation of America (DYSL) | $0.84 | - | - | 13.5M | Strong Buy |
| ImmuCell Corporation (ICCC) | $5.39 | - | - | 38.6M | Strong Buy |
| STRATA Skin Sciences Inc (SSKN) | $1.41 | - | - | 54.3M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
